02/05/2025
4:41 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
5:55 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
5:58 PM | Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
5:43 PM | Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
5:46 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
5:50 PM | GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
5:40 PM | Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
6:45 AM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/06/2025
3:22 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
3:43 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/09/2024
5:45 PM | GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for JAZZ and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Jazz Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
12/02/2024
5:05 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/02/2024
3:20 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/26/2024
4:02 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2024
5:06 AM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
4:44 PM | Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/12/2024
10:44 AM | BlackRock, Inc. (Filed by)
Jazz Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/08/2024
4:55 PM | Jazz Pharmaceuticals (Subject)
Patil Neena M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2024
6:32 AM | Jazz Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
3:06 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
4:00 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
2:19 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/21/2024
3:11 PM | BlackRock, Inc. (Filed by)
Jazz Pharmaceuticals (Subject)
| Form SC 13G/A | |
10/16/2024
3:13 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2024
10:38 AM | Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:50 PM | Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024
1:27 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
5:39 PM | Cook Jennifer E. (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
5:39 PM | Jazz Pharmaceuticals (Issuer)
McSharry Heather Ann (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
5:40 PM | Jazz Pharmaceuticals (Issuer)
O'Keefe Kenneth W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
5:40 PM | Jazz Pharmaceuticals (Issuer)
ORiordan Anne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
5:41 PM | Jazz Pharmaceuticals (Issuer)
RIEDEL NORBERT G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
5:42 PM | Jazz Pharmaceuticals (Issuer)
Smith Mark Douglas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
5:42 PM | Jazz Pharmaceuticals (Issuer)
Winningham Rick E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
5:45 PM | ENRIGHT PATRICK G (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:48 PM | Hamill Laura (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:50 PM | Jazz Pharmaceuticals (Issuer)
Kennedy Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:52 PM | Jazz Pharmaceuticals (Issuer)
Mulligan Seamus (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2024
3:53 PM | Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
8:57 PM | Jazz Pharmaceuticals (Subject)
Winningham Rick E (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2024
8:29 PM | Jazz Pharmaceuticals (Subject)
McSharry Heather Ann (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
This Crypto Is Set to Explode in February (Ad) It's a groundbreaking opportunity that could be poised for extraordinary gains.
The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW |
08/05/2024
8:35 PM | Jazz Pharmaceuticals (Subject)
O'Keefe Kenneth W (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2024
8:42 PM | Jazz Pharmaceuticals (Subject)
ORiordan Anne (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2024
8:49 PM | Jazz Pharmaceuticals (Subject)
RIEDEL NORBERT G (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2024
8:55 PM | Jazz Pharmaceuticals (Subject)
Smith Mark Douglas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2024
8:19 PM | Cook Jennifer E. (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024
6:33 AM | Jazz Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/31/2024
3:06 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
7:11 PM | Hamill Laura (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/22/2024
3:46 PM | Jazz Pharmaceuticals (Filer)
| Form DEFA14A | |
07/22/2024
6:57 AM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2024
7:15 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:44 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2024
4:31 PM | Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
6:38 AM | Jazz Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/09/2024
3:39 PM | GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
5:07 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
8:49 PM | Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
8:53 PM | GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
8:44 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
8:47 PM | Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
8:48 PM | Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2024
5:09 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2024
6:54 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:58 PM | Henderson Mary Elizabeth (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:28 PM | Jazz Pharmaceuticals (Issuer)
Johnson Philip L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:32 PM | Jazz Pharmaceuticals (Issuer)
Kennedy Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:34 PM | COZADD BRUCE C (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:44 PM | GALA RENEE D (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:47 PM | Iannone Robert (Reporting)
Jazz Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:50 PM | Jazz Pharmaceuticals (Issuer)
Patil Neena M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:52 PM | Jazz Pharmaceuticals (Issuer)
Pearce Samantha (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
6:11 PM | Jazz Pharmaceuticals (Issuer)
Kennedy Patrick (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/05/2024
6:14 PM | Jazz Pharmaceuticals (Issuer)
Johnson Philip L (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/01/2024
2:11 PM | Carr Patricia (Reporting)
Jazz Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2024
3:06 PM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2024
6:45 AM | Jazz Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
